Prehabilitation in Pancreatic Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorIRCCS San Raffaele

About this trial

In patients with pancreatic cancer, older age, multiple comorbidities, frailty, malnutrition and poor functional status are common, especially in individuals receiving neoadjuvant chemotherapy. These characteristics represent potentially modifiable risk factors for poor postoperative outcomes.

The goal of this clinical randomized controlled trial is to evaluate the extent to which a four-week multimodal prehabilitation program impacts on postoperative morbidity, functional and nutritional status and health-related quality of life in patients with localized pancreatic or periampullary cancer scheduled for curative surgery.

In addition, the impact of prehabilitation on circulating sarcopenia and cancer cachexia biomarkers in PDAC patients will be explored.

Included patients will be randomized (ratio 1:1) and allocated either to the intervention group (Multimodal Prehabilitation), which will receive prehabilitation, or to the control group, which will receive no prehabilitation.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥ 18 years

Indication for curative resection for pancreatic or periampullary cancer

Signed Informed consent

Disqualifiers

Metastatic or unresectable disease found preoperatively

Comorbidities contraindicating prehabilitation regimen (exercise and nutritional intervention) such as orthopedic, cognitive disabilities, chronic renal failure (dialysis or creatinine >250 mmol)

ASA score 4-5

Pregnancy

Trial design

Design model

Parallel

Treatments tested in this trial

  • Multimodal Prehabilitation

    Other intervention

    Preoperative multimodal intervention including exercise training, nutritional therapy and psychosocial counseling, aimed at preventing or attenuating surgery-driven functional decline. A personalized intervention program will be prescribed based on specific physical, nutritional and psychological conditions recognized during the multimodal assessment. Patients will follow a 2 to 3-day per week exercise program for 4-6 weeks including endurance, resistance, and inspiratory muscle training, tailored to individual preferences and clinical conditions. Based on dietary habits and nutritional status, a certified nutritionist will provide a comprehensive diet management program. A food-based intervention with a balanced macronutrient composition coupled with oral nutritional supplements will be prescribed to achieve the estimated daily energy and protein requirements. Patients will meet with a psychologist to explore their emotional and psychosocial needs related to their current situation.

Treatment groups

238 Participants
are divided into 2 treatment groups
Group A: Multimodal PrehabilitationExperimental treatment 1 intervention
Group B: Usual careNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Comprehensive Complication Index (CCI)

Postoperative complications occurring during the index admission or in a subsequent readmission, when related to surgery, will be recorded up to 90 days after surgery and graded by severity using the Dindo-Clavien classification and the Comprehensive Complication index (CCI). The Dindo-Clavien system grades complications according to the therapy needed for treatment: Grade I, are complications that require bedside management; Grade II, are complications that require pharmacologic treatment; Grade III, are complications that require surgical or radiologic intervention and; Grade IV, are complications that require intensive care treatment. Dindo-Clavien Grade III or above are considered severe postoperative complications. The CCI, derived from the Dindo-Clavien system, is a validated metric summarizing the complete spectrum of complications that occurred and their severity in a single score ranging from 0 to 100.

Time frame
90 days after surgery

Secondary outcomes

1

Time to patient functional recovery (TFR)

TFR will be measured by subtracting the date of surgery from the date when participants achieve standardized criteria (tolerance of oral intake, recovery of lower gastrointestinal function, adequate pain control on oral analgesia, ability to mobilize and self-care and no evidence of untreated medical problems)

Time frame
90 days after surgery
2

Lenght of stay (LOS)

LOS will be measured by subtracting the date of surgery from the date of discharge

Time frame
90 days after surgery
3

Functional capacity

Functional capacity will be measured by the 6-minute walking test, timed up and go test (TUG), gait speed assessment, handgrip strength test, and compared between groups on the day before surgery, at 30-60-90 days after surgery.

Time frame
One day before surgery; 30 days after surgery; 60 days after surgery; 90 days after surgery
4

Nutritional status

Nutritional status will be measured by weight (kg), height (cm), and body mass index (kg/m2), and nutritional screening questionnaires (mini nutritional assessment - MNA, patient-generated - subjective global assessment - PG-SGA) and compared between groups at baseline, on the day before surgery, at 30, 60, 90 days after surgery..

Time frame
One day before surgery; 30 days after surgery; 60 days after surgery; 90 days after surgery.

Other outcomes

1

Hospital costs

Hospital-related costs will be collected for all patients included in the study over a 90-day postoperative period. These costs include expenses directly associated with patient care, such as the prehabilitation program (staff time, facilities, equipment, and sessions), surgical procedures, length of hospital stay, management of complications, remissions, and follow-up visits within 90 days after surgery. Comparing hospital costs between patients receiving prehabilitation and those undergoing standard care will provide valuable insight into the economic impact of prehabilitation on healthcare resource utilization during the early postoperative period.

Time frame
90 days after surgery

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

IRCCS San Raffaele

Lead sponsor

Ministero della Salute, Italy

Collaborator